Meeder Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8
| Closed | -$1K | – | 2051 |
|
|
2022
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 2038 |
|
|
2022
Q2 | $1K | Sell |
8
-11
| -58% | -$1.38K | ﹤0.01% | 2098 |
|
|
2022
Q1 | $2K | Hold |
19
| – | – | ﹤0.01% | 2094 |
|
|
2021
Q4 | $2K | Buy |
19
+8
| +73% | +$842 | ﹤0.01% | 1002 |
|
|
2021
Q3 | $1K | Sell |
11
-8
| -42% | -$727 | ﹤0.01% | 2389 |
|
|
2021
Q2 | $3K | Hold |
19
| – | – | ﹤0.01% | 2139 |
|
|
2021
Q1 | $3K | Hold |
19
| – | – | ﹤0.01% | 2013 |
|
|
2020
Q4 | $3K | Buy |
19
+10
| +111% | +$1.58K | ﹤0.01% | 1408 |
|
|
2020
Q3 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 2068 |
|
|
2020
Q2 | – | Sell |
-5
| Closed | – | – | 2516 |
|
|
2020
Q1 | $0 | Sell |
5
-41
| -89% | – | ﹤0.01% | 2567 |
|
|
2019
Q4 | $4K | Buy |
46
+26
| +130% | +$2.26K | ﹤0.01% | 1868 |
|
|
2019
Q3 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 1998 |
|